evolocumab /ˌɛv.əˈlɑk.jəˌmæb/ noun1 •A human monoclonal antibody designed for the treatment of hyperlipidemia.So was Repatha, or evolocumab, a similar drug developed by Amgen that is expected to win F.D.A. approval by the end of August. — 2015
